OQRO

Weekly recap

Insider trades and Congress trades, week of Oct 27 – Nov 2, 2025

In the week of Oct 27 – Nov 2, 2025, insiders filed 89 open-market purchases worth about $174M and 539 open-market sales; the largest purchase was $92.5M of Maplight Therapeutics (MPLT) by Catalyst4; members of Congress disclosed 22 purchases and 1 sales; 10 purchases stood out against the company's record since 2006.

By filing date, Monday to Sunday. Every line links to its SEC, House or Senate record. Public filings, not investment advice.

Purchases that stand out against 20 years of filings

Measured against every open-market trade the company's insiders filed since 2006. See all of them on the rare insider trades page.

Largest insider purchases

Largest insider sales

Congress trades disclosed

Members report a value range, not an exact amount; the trade can be up to 45 days older than its report.

Executives who announced they are leaving

  • Regal Rexnord (RRX) · Oct 31, 2025

    “On October 29, 2025, Regal Rexnord Corporation (the “Company”) announced that Louis Pinkham, the Company’s Chief Executive Officer will separate from his role with the Company in connection with a Chief Executive Officer (“CEO”) search process being led by the Company’s Board of Directors (the “Board”).” 8-K

  • Barnwell Industries (BRN) · Oct 31, 2025

    “On October 27, 2025, Barnwell Industries, Inc. (the “Company”) appointed Philip F. Patman, Jr. as the Company’s Executive Vice President – Finance. On October 27, 2025, the Company also issued a press release announcing the planned retirement of Russell Gifford, the Company’s long-serving Chief Financial Officer.” 8-K

  • Rtb Digital (RTB) · Oct 31, 2025

    “On October 28, 2025, Fredi Nisan notified the board of directors of RYVYL Inc., a Nevada corporation (the “Company”), of his resignation as a director of the Company, effective on October 30, 2025.” 8-K

  • Srx Global (SRXH) · Oct 31, 2025

    “On October 31, 2025, the Company accepted the voluntary resignation of each of Lionel F. Conacher and David Allen White from the Company’s Board of Directors, effective immediately.” 8-K

  • Phio Pharmaceuticals (PHIO) · Oct 31, 2025

    “On October 31, 2025, Robert Ferrara resigned, effective immediately, from his position as a director of Phio Pharmaceutical Corp.’s (the “Company’s”) Board of Directors (the “Board”), including his memberships on the Compensation Committee and the Audit Committee, and as Lead Independent Director of the Board.” 8-K

  • Aterian (ATER) · Oct 31, 2025

    “On October 30, 2025, Roi Zahut, Chief Technology Officer of Aterian, Inc. (the “Company”), notified the Company of his decision to resign, effective November 3, 2025 (the “Effective Date”), to accept another executive position outside the Company.” 8-K

  • Bakkt (BKKT) · Oct 31, 2025

    “On October 31, 2025, David Clifton notified the Board of Directors (the “Board”) of Bakkt Holdings, Inc. (the “Company”) of his decision to resign as a director of the Company, effective immediately.” 8-K

  • Interactive Strength (TRNR) · Oct 31, 2025

    “On October 27, 2025, Michael J. Madigan informed Interactive Strength Inc. (the “Company”) of his decision to resign from his position as the Chief Financial Officer of the Company, effective November 14, 2025.” 8-K

The company's own words, from the opening sentence of its Form 8-K (Item 5.02).

5% stakes filed (Schedules 13D and 13G)

Largest federal contract awards

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Kinder Morgan free$9.99 a month, cancel anytime